MAPT and Alzheimer disease: Significant and bidirectional interactions between AD and various forms of vascular pathology have been well documented [13]; amyloid and tau toxicity disrupts the blood–brain barrier (BBB) and alters vascular permeability, and structural or functional damage to cerebral vasculature impairs amyloid clearance and promotes tau aggregation.